Zaxis International Inc. Announces Multi-Year Supply Agreement With Visible Genetics Inc.
During January this stock has been trading between 13/16 and $4. Currently around $2 7/8 with increased volume.
Anyone on this thread following the stock or understand the financial potential of ZAXS' technology ?
Cheers, Henrik
==========================================================
biz.yahoo.com
HUDSON, Ohio--(BUSINESS WIRE)--Jan. 26, 2000--Zaxis International Inc. (OTCBB:ZAXS - news) and Visible Genetics Inc.
(Nasdaq:VGIN - news) today announced the signing of a multi-year agreement under which Zaxis International will supply Visible
Genetics with the SureFill(TM) gel cartridge used with their OpenGene(TM) Automated DNA Sequencing System.
``This contract is another confirmation of our plan to become the number one supplier of consistent, reliable and the highest quality
DNA gels for the leading manufacturers of high performance automated DNA sequencing systems,' said John Hrobsky, president
and CEO of Zaxis International. In addition to providing proprietary products to Visible Genetics, Zaxis will provide technical
assistance and product development support.
David Gibbons, vice president of product support & development for Visible Genetics, stated, ``We are pleased to secure our
source of supply for our OpenGene(TM) System and to be associated with a high quality manufacturer like Zaxis International.'
The OpenGene(TM) System employs proprietary stratified DNA testing and single-tube, single step sequencing methods which
reduce the time and cost involved in identifying clinically important genetic information.
Zaxis International Inc. is a biotechnology company that produces electrophoresis gels for testing blood proteins and various
genetic compounds. Zaxis produces these gels for the research and clinical markets. The company is a leader in this high growth
market and is poised to take advantage of its leading edge technology.
Statements in this press release that relate to matters that are not historic fact are forward-looking statements that involve market
risks and uncertainties including, but not limited to, the ability of Zaxis International to develop and commercialize the products that
are subject to this program and other risks and uncertainties in the company's Securities and Exchange filings. |
